找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cervagem; A new prostaglandin Sultan M. M. Karim ((Symposium Chairman and Procee Conference proceedings 1983 MTP Press Limited 1983 Pessar

[復(fù)制鏈接]
樓主: T-Lymphocyte
31#
發(fā)表于 2025-3-26 21:02:54 | 只看該作者
32#
發(fā)表于 2025-3-27 03:15:11 | 只看該作者
33#
發(fā)表于 2025-3-27 08:24:35 | 只看該作者
Lecture Notes in Computer ScienceIn this first Cervagem International Symposium we have heard today the detailed results of closely monitored, controlled clinical trials with this new product. In many cases it has been our good fortune to receive the information from the best possible source — the investigators themselves.
34#
發(fā)表于 2025-3-27 09:45:40 | 只看該作者
35#
發(fā)表于 2025-3-27 14:31:03 | 只看該作者
Welfare effects of parallel trade,I am sure all of you will agree with me that this has been a stimulating afternoon. I am not going to detain you any longer by summarizing this afternoon’s proceedings which will be published later.
36#
發(fā)表于 2025-3-27 18:05:39 | 只看該作者
Clinical applications of prostaglandins in obstetrics and gynaecology,The use of prostaglandins in obstetrics and gynaecology is now firmly established. Most applications in this area are based on the ability of prostaglandins to modify the activity of the human uterus. This property was first recognized in 1930 and has since been confirmed by numerous investigators using pure prostaglandins.
37#
發(fā)表于 2025-3-28 01:57:08 | 只看該作者
38#
發(fā)表于 2025-3-28 02:49:52 | 只看該作者
39#
發(fā)表于 2025-3-28 08:19:47 | 只看該作者
Cervagem future development: proposed clinical evaluation by the prescriber,For the purpose of this evaluation, the normal prescribing information for Cervagem has been transcribed into a protocol format. Cervagem is indicated for ., and the protocol is set out here.
40#
發(fā)表于 2025-3-28 14:19:33 | 只看該作者
,Chairman’s concluding remarks,I am sure all of you will agree with me that this has been a stimulating afternoon. I am not going to detain you any longer by summarizing this afternoon’s proceedings which will be published later.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 10:03
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
麟游县| 德令哈市| 延吉市| 措勤县| 突泉县| 二连浩特市| 松阳县| 延川县| 浏阳市| 建水县| 奈曼旗| 邢台市| 林周县| 高碑店市| 东兰县| 磐安县| 东至县| 东乡族自治县| 辽源市| 区。| 安福县| 两当县| 金塔县| 嘉善县| 静宁县| 浙江省| 和田县| 淅川县| 桃园县| 定结县| 阿鲁科尔沁旗| 瓮安县| 微博| 漳州市| 明水县| 柳州市| 曲松县| 开鲁县| 繁峙县| 乐平市| 乐昌市|